1. Home
  2. HCAT vs SGMO Comparison

HCAT vs SGMO Comparison

Compare HCAT & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

HOLD

Current Price

$2.72

Market Cap

174.0M

Sector

Technology

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.50

Market Cap

155.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAT
SGMO
Founded
2008
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.0M
155.1M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
HCAT
SGMO
Price
$2.72
$0.50
Analyst Decision
Hold
Buy
Analyst Count
11
7
Target Price
$4.30
$4.71
AVG Volume (30 Days)
858.1K
9.6M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$316,063,000.00
$32,875,000.00
Revenue This Year
$3.23
$28.47
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.63
N/A
52 Week Low
$2.02
$0.38
52 Week High
$8.91
$2.84

Technical Indicators

Market Signals
Indicator
HCAT
SGMO
Relative Strength Index (RSI) 49.60 52.17
Support Level $2.02 $0.42
Resistance Level $3.03 $0.48
Average True Range (ATR) 0.23 0.05
MACD 0.06 0.01
Stochastic Oscillator 69.80 67.00

Price Performance

Historical Comparison
HCAT
SGMO

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: